Skip to main content
ArcticZymes Technologies logo

ArcticZymes Technologies — Investor Relations & Filings

Ticker · AZT ISIN · NO0010014632 LEI · 5967007LIEEXZXGR7K47 BR Manufacturing
Open in API
Filings indexed 968 across all filing types
Latest filing 2022-10-14 Share Issue/Capital Cha…
Country NO Norway
Listing BR AZT

About ArcticZymes Technologies

https://arcticzymes.com/

ArcticZymes Technologies is a life sciences company specializing in the development, manufacturing, and commercialization of novel recombinant enzymes. Leveraging over 30 years of expertise, the company discovers and engineers enzymes from cold-adapted Arctic marine organisms. These enzymes are designed to solve specific challenges in molecular applications, demonstrating high efficiency in demanding conditions such as low temperatures and high salinity. The product portfolio, including Salt Active Nucleases (SAN) and Cod Uracil-DNA Glycosylase, serves global partners in molecular diagnostics, gene therapy, vaccine production, and biomanufacturing. All products are manufactured at its ISO 13485 certified facility, ensuring high quality and performance for research and commercial use.

Recent filings

Filing Released Lang Actions
ArcticZymes Technologies ASA: Registration of share capital following exercise of options
Share Issue/Capital Change Classification · 98% confidence The document explicitly announces the 'Registration of share capital following exercise of options' and details the resulting change in the number of shares and the new total share capital (NOK 50,571,390 divided into 50,571,390 shares). This directly relates to a change in the company's capital structure due to the issuance of new shares following option exercises. This aligns perfectly with the definition of 'Share Issue/Capital Change' (Code: SHA). It is not a general financing update (CAP), nor a dividend notice (DIV), nor a transaction in own shares (POS), as POS typically refers to buybacks or direct treasury transactions, whereas SHA covers the resulting capital structure change from option exercises.
2022-10-14 English
ArcticZymes Technologies ASA: Increase of share capital related to exercise of options by former employee
Share Issue/Capital Change Classification · 98% confidence The document explicitly announces an 'Increase of share capital related to exercise of options by former employee'. It details the resolution by the Board of Directors to increase the share capital by issuing 200,000 new shares. This directly relates to changes in the company's capital structure through the issuance of new shares, which aligns perfectly with the definition of 'Share Issue/Capital Change' (Code: SHA). The document is short and is an announcement, but the content itself is the primary event (capital change), not just an announcement of another report, making SHA more specific than RPA or RNS.
2022-10-05 English
ArcticZymes Technologies ASA: Increase of share capital related to exercise of options by former employee
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces an 'Increase of share capital related to exercise of options by former employee'. It details the resolution by the Board of Directors to issue 200,000 new shares, resulting in a new total share capital amount. This directly relates to changes in the company's capital structure through the issuance of new shares, which aligns precisely with the definition of 'Share Issue/Capital Change' (Code: SHA). The document is short and serves as a direct announcement of this corporate action.
2022-10-05 English
ArcticZymes Technologies to present at Pareto Securities' 13th Annual Healthcare Conference
Investor Presentation Classification · 98% confidence The document is a highly visual presentation containing slides with titles like 'Specialist supplier of best-in-class novel enzymes', 'Our Novel Enzyme Products', 'Financial Performance' (showing H1 2022 sales contribution and quarterly figures), 'Growth Strategy', and concluding with a 'Q&A Session'. It includes financial guidance for 2022 and 2025, and a standard forward-looking statements disclaimer typical of investor materials. This structure strongly indicates an Investor Presentation (IP) or materials prepared for an Annual General Meeting (AGM-R). Since it focuses heavily on strategy, product portfolio, and financial outlook presented in a slide format, Investor Presentation (IP) is the most fitting category. It is not a full Annual Report (10-K), a short Earnings Release (ER), or a formal Audit Report (AR).
2022-09-08 English
ArcticZymes Technologies to present at Pareto Securities' 13th Annual Healthcare Conference
Report Publication Announcement Classification · 95% confidence The document is very short (654 characters) and announces that ArcticZymes Technologies will present at the Pareto Securities' 13th Annual Healthcare Conference on September 8, 2022. It explicitly states, 'Please find the presentation enclosed'. This structure—an announcement about participation in an event where a presentation will be given, with the presentation material enclosed—strongly suggests this is an announcement about the presentation itself, rather than the full presentation (IP) or a general regulatory filing. Since the document is announcing participation in a specific event and enclosing the material, it fits best under the category for announcements regarding the publication or release of company materials, which is Report Publication Announcement (RPA). It is not a full report (10-K, IR), a transcript (CT), or a general regulatory filing (RNS) as a more specific category applies.
2022-09-08 English
Major shareholder disclosure in ArcticZymes Technologies ASA
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled "Standard form for notification of major holdings" and contains sections detailing the 'Reason for the notification' (An acquisition or disposal of voting rights), the 'Date on which the threshold was crossed or reached' (2022-08-30), and the resulting percentage of voting rights (9.94996%). This structure is characteristic of regulatory filings related to changes in significant share ownership thresholds. This directly corresponds to the definition for Major Shareholding Notification (MRQ).
2022-08-30 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.